Clinical Trials · NCT04261933
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 789
- Start date
- Feb 2020
- Locations
- 95 sites, Germany
- Primary endpoint
- Change in Glycated Haemoglobin A1c (HbA1c)